AMRN [NASD]
Amarin Corporation plc
Index- P/E- EPS (ttm)-0.25 Insider Own0.30% Shs Outstand398.19M Perf Week0.00%
Market Cap484.19M Forward P/E- EPS next Y-0.20 Insider Trans4.72% Shs Float381.31M Perf Month-6.30%
Income-100.00M PEG- EPS next Q-0.06 Inst Own35.30% Short Float2.51% Perf Quarter-24.20%
Sales475.60M P/S1.02 EPS this Y140.70% Inst Trans2.40% Short Ratio2.87 Perf Half Y-67.31%
Book/sh1.46 P/B0.82 EPS next Y37.50% ROA-9.90% Target Price3.57 Perf Year-75.81%
Cash/sh0.77 P/C1.55 EPS next 5Y38.90% ROE-15.80% 52W Range1.04 - 5.24 Perf YTD-64.69%
Dividend- P/FCF- EPS past 5Y15.40% ROI1.00% 52W High-77.29% Beta1.85
Dividend %- Quick Ratio1.40 Sales past 5Y35.00% Gross Margin75.00% 52W Low14.42% ATR0.08
Employees560 Current Ratio2.00 Sales Q/Q-38.90% Oper. Margin-18.50% RSI (14)47.86 Volatility6.96% 6.94%
OptionableYes Debt/Eq0.00 EPS Q/Q- Profit Margin-21.00% Rel Volume0.30 Prev Close1.21
ShortableYes LT Debt/Eq0.00 EarningsAug 03 BMO Payout- Avg Volume3.33M Price1.19
Recom3.00 SMA20-1.00% SMA50-9.16% SMA200-48.31% Volume1,009,011 Change-1.65%
May-06-22Downgrade JP Morgan Neutral → Underweight
May-05-22Downgrade SVB Leerink Outperform → Mkt Perform $10 → $3
May-05-22Downgrade H.C. Wainwright Buy → Neutral $10 → $3
May-04-22Downgrade Northland Capital Outperform → Market Perform
May-12-21Downgrade Goldman Neutral → Sell $6 → $5
Sep-29-20Resumed JP Morgan Neutral
Aug-26-20Initiated Piper Sandler Overweight $21
May-05-20Initiated Northland Capital Outperform $15
Mar-31-20Upgrade Oppenheimer Underperform → Perform
Mar-31-20Downgrade Jefferies Buy → Hold $30 → $4
Mar-31-20Downgrade Goldman Buy → Neutral
Mar-13-20Upgrade Goldman Neutral → Buy $28
Mar-02-20Initiated Cowen Outperform $23
Feb-18-20Upgrade Citigroup Neutral → Buy $27 → $24
Jan-06-20Initiated JP Morgan Neutral $22
Dec-16-19Downgrade Stifel Buy → Hold
Nov-20-19Initiated Oppenheimer Underperform $7
Nov-18-19Downgrade Citigroup Buy → Neutral
Nov-15-19Reiterated SVB Leerink Outperform $26 → $29
Oct-31-19Initiated Aegis Capital Buy $23
Aug-30-22 08:00AM
Aug-29-22 07:16AM
Aug-28-22 05:51AM
Aug-26-22 12:08PM
09:17AM
08:19AM Loading…
08:19AM
Aug-25-22 12:35PM
Aug-15-22 08:00AM
Aug-04-22 01:05PM
Aug-03-22 07:00PM
03:27PM
12:51PM
07:00AM
Jul-20-22 08:00AM
Jul-15-22 09:22AM
08:00AM Loading…
Jul-13-22 08:00AM
Jul-01-22 11:40AM
Jun-30-22 04:05PM
Jun-15-22 04:50PM
Jun-10-22 10:23AM
06:00AM
Jun-06-22 11:18AM
08:30AM
08:15AM
Jun-03-22 05:57PM
Jun-01-22 07:08PM
May-24-22 07:28AM
May-19-22 08:23AM
May-16-22 08:00AM
May-13-22 06:34AM
08:00AM Loading…
May-12-22 08:00AM
May-05-22 11:30AM
May-04-22 07:30PM
10:51AM
07:00AM
May-03-22 08:00AM
Apr-26-22 08:49AM
Apr-19-22 07:30AM
Apr-01-22 07:00AM
Mar-31-22 10:06AM
Mar-28-22 07:00AM
Mar-21-22 08:30AM
Mar-10-22 08:47AM
Mar-02-22 10:29AM
Mar-01-22 01:00PM
06:00AM
Feb-25-22 08:00AM
Feb-24-22 07:30AM
Feb-15-22 08:00AM
Feb-01-22 05:38PM
Jan-31-22 05:38PM
Jan-28-22 08:23AM
Jan-18-22 08:15AM
Jan-12-22 12:11PM
09:38AM
Jan-10-22 07:00AM
Jan-04-22 07:00AM
04:10AM
Dec-27-21 06:09AM
Dec-22-21 04:00PM
07:00AM
Dec-21-21 09:41PM
06:38PM
05:17PM
03:45PM
Dec-20-21 09:50AM
Dec-19-21 07:29PM
Dec-17-21 06:19PM
11:45AM
Dec-16-21 06:30PM
04:00PM
09:30AM
Dec-15-21 05:37PM
01:15PM
Dec-14-21 09:00PM
06:20PM
12:00PM
10:00AM
09:50AM
Dec-13-21 10:15PM
01:30PM
Dec-10-21 03:05PM
Dec-09-21 09:00PM
08:45PM
04:30PM
02:55PM
11:00AM
Dec-08-21 10:35AM
08:42AM
Dec-07-21 11:34PM
05:03PM
02:15PM
01:38PM
Dec-06-21 02:30PM
09:35AM
Dec-03-21 07:44PM
05:26AM
Dec-02-21 11:32PM
09:15PM
07:45PM
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally to wholesalers and specialty pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, and eicosapentaenoic acid. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
WOLD OLSEN PERDirectorJun 13Buy1.6955,00092,730149,000Jun 15 08:01 PM
Zakrzewski Joseph SDirectorDec 15Buy3.152,0006,310196,547Dec 16 08:01 PM
Zakrzewski Joseph SDirectorDec 14Buy3.2710,00032,689194,547Dec 16 08:01 PM